Physician profile
Bin Bin Fan
NPI 1821642216
$18,948.19
in general payments reported to CMS, 2019-2025
28 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $828 · 2022: $943 · 2023: $1,379 · 2024: $3,081 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,525 · Food and Beverage: $7,367 · Education: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,525.00 |
| Food and Beverage | $7,367.44 |
| Education | $284.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $10,416.19 | 2021-2025 | Nemluvio, Aklief, Oracea |
| Novartis Pharmaceuticals Corporation | $1,027.41 | 2022-2025 | |
| Incyte Corporation | $1,020.94 | 2022-2025 | Opzelura, Opzelura |
| Dermavant Sciences, INC. | $908.66 | 2023-2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $650.96 | 2021-2025 | Ilumya |
| Genzyme Corporation | $579.96 | 2022-2025 | |
| Pfizer INC. | $552.33 | 2022-2025 | |
| Abbvie INC. | $504.15 | 2021-2025 | |
| Lilly USA, LLC | $502.99 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $400.59 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $388.04 | 2024-2025 | Adbry, Anzupgo |
| Ucb, INC. | $340.63 | 2021-2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $322.46 | 2024-2025 | Zoryve |
| Janssen Biotech, INC. | $273.38 | 2024-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $207.61 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $146.07 | 2022-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $109.58 | 2021-2025 | Siliq |
| Janssen Scientific Affairs, LLC | $90.93 | 2022 | |
| Amgen INC. | $89.79 | 2023-2024 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.89 | 2023-2024 | Spevigo, Cyltezo |
| Organon LLC | $62.52 | 2025 | Vtama |
| Mayne Pharma Commercial LLC | $56.65 | 2024-2025 | |
| Cipher Pharmaceuticals US LLC | $49.46 | 2025 | Natroba, Spinosad |
| Vyne Pharmaceuticals INC. | $47.82 | 2021 | |
| Strata Skin Sciences, INC. | $41.36 | 2024-2025 | Xtrac |
| Biofrontera INC. | $34.34 | 2022-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Allergan, INC. | $29.89 | 2021 | |
| Paratek Pharmaceuticals, INC. | $18.59 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bin Bin Fan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.